Results found for paxlovid | Eastern NC Now

Your source for all Eastern NC Events, Issues, Business, News and Information, Government, Politics, People, and Arts. Everything a tourist, and others alike need.

ENCNow
Home
Categories
Login
Advertisement
VbAD0
Latest Polls   (view all)
Where do you stand on the Transgender Issue now that the issue has gotten to the overt point of the open celebration of this lifestyle choice, dictated by certain direct and explicit actions.
91.07% I do not approve of behavior that has within its expressed tenants policies that harm children.
8.04% I do support the Trans Community in all its many facets because diversity is at a premium in today's society.
0.89% What is a "Children's Drag Queen Story Hour?"
Advertisement
VbAD1
Latest Comments   (view all)
Advertisement
VbAD2
Latest Entries   (view all)
Advertisement
VbAD3
ENCN Masthead
ENCN Masthead

Results found for "paxlovid"


Pfizer’s COVID pill reportedly offered no measurable benefit for adults 40 to 65, according to a study published on Wednesday.
Published: Tuesday, September 6th, 2022 @ 8:43 pm By: Daily Wire
Pfizer’s COVID pill reportedly offered no measurable benefit for adults 40 to 65, according to a study published on Wednesday.
 
Big pharma's way of keeping covid alive
Big pharma's way of keeping covid alive
 
RALEIGH: Today, Governor Roy Cooper tested positive for COVID-19. The Governor is experiencing mild symptoms. He has begun taking Paxlovid, an oral antiviral pill to treat COVID-19. Governor Cooper is vaccinated against the virus and has received two booster shots.
RALEIGH: Today, Governor Roy Cooper tested positive for COVID-19. The Governor is experiencing mild symptoms. He has begun taking Paxlovid, an oral antiviral pill to treat COVID-19. Governor Cooper is vaccinated against the virus and has received two booster shots.
 
This week, the New York Department of Health published an announcement to health care providers and health care facilities regarding two COVID-19 oral antiviral therapies: Paxlovid, created by Pfizer, and molnupiravir, from Merck, and apparently discriminated against whites.
Published: Monday, January 3rd, 2022 @ 8:33 am By: Daily Wire
This week, the New York Department of Health published an announcement to health care providers and health care facilities regarding two COVID-19 oral antiviral therapies: Paxlovid, created by Pfizer, and molnupiravir, from Merck, and apparently discriminated against whites.
 

HbAD0

 
 
Back to Top